Literature DB >> 32757101

Examining the Potential of Pre-exposure Prophylaxis (PrEP) for HIV Prevention in a Community Sample of Persons Who Use Stimulants Living in the Southern United States.

Sheri L Towe1, Catherine A Sullivan2, Mehri S McKellar3, Christina S Meade2.   

Abstract

Pre-exposure prophylaxis (PrEP), a highly effective HIV prevention strategy, is currently underutilized by several at-risk groups, including both persons who inject drugs and those who use drugs via other routes. Stimulant use is associated with increased HIV risk due to both sexual and injection risk behaviors. In this study, we examined PrEP awareness and acceptability in persons with biologically confirmed HIV-negative status who use stimulant drugs. We also examined HIV risk behaviors to identify how many participants met behavioral eligibility for PrEP. The sample of 352 participants was 46% female, 87% African American, and 45.69 years old on average. Over half the sample (n = 213) met criteria for PrEP candidacy, but less than 20% had heard of PrEP. Ratings for willingness to take PrEP were high. PrEP candidates reported more frequent and problematic stimulant use relative to non-candidates. Our results show that persons who use stimulants are a high-risk population that could benefit significantly from PrEP. Efforts to increase PrEP awareness among high-risk populations are critical for facilitating PrEP implementation and ensuring effective HIV prevention within these communities.

Entities:  

Keywords:  Cocaine; HIV; Pre-exposure prophylaxis; Stimulants

Mesh:

Year:  2021        PMID: 32757101      PMCID: PMC7862414          DOI: 10.1007/s10461-020-02987-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  49 in total

1.  Ending the HIV Epidemic: A Plan for the United States.

Authors:  Anthony S Fauci; Robert R Redfield; George Sigounas; Michael D Weahkee; Brett P Giroir
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

2.  Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.

Authors:  Angela R Bazzi; Dea L Biancarelli; Ellen Childs; Mari-Lynn Drainoni; Alberto Edeza; Peter Salhaney; Matthew J Mimiaga; Katie B Biello
Journal:  AIDS Patient Care STDS       Date:  2018-10-11       Impact factor: 5.078

3.  Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los Angeles.

Authors:  David Goodman-Meza; Matthew R Beymer; Ryan M Kofron; K Rivet Amico; Christina Psaros; Lane R Bushman; Peter L Anderson; Robert Bolan; Wilbert C Jordan; James F Rooney; Amy R Wohl; Raphael J Landovitz
Journal:  AIDS Care       Date:  2019-03-20

4.  Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Roger Chou; Christopher Evans; Adam Hoverman; Christina Sun; Tracy Dana; Christina Bougatsos; Sara Grusing; P Todd Korthuis
Journal:  JAMA       Date:  2019-06-11       Impact factor: 56.272

5.  Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis.

Authors:  Roman Shrestha; Pramila Karki; Tania B Huedo-Medina; Michael Copenhaver
Journal:  J Assoc Nurses AIDS Care       Date:  2017-04-19       Impact factor: 1.354

6.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Authors:  Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-06-15       Impact factor: 3.797

7.  PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives.

Authors:  Anya Y Spector; Robert H Remien; Susan Tross
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-01-08

8.  Skating on thin ice: stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis.

Authors:  J Carlo Hojilla; David Vlahov; David V Glidden; K Rivet Amico; Megha Mehrotra; Robert Hance; Robert M Grant; Adam W Carrico
Journal:  J Int AIDS Soc       Date:  2018-03       Impact factor: 5.396

9.  Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.

Authors:  K B Biello; A R Bazzi; M J Mimiaga; D L Biancarelli; A Edeza; P Salhaney; E Childs; M L Drainoni
Journal:  Harm Reduct J       Date:  2018-11-12

10.  Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis - United States, 2013-2018.

Authors:  Norma S Harris; Anna Satcher Johnson; Ya-Lin A Huang; Dayle Kern; Paul Fulton; Dawn K Smith; Linda A Valleroy; H Irene Hall
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-12-06       Impact factor: 17.586

View more
  1 in total

1.  Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake Among Men Who have Sex with Men Who Use Stimulants: A Qualitative Study.

Authors:  Adam Viera; Jacob J van den Berg; Collette D Sosnowy; Nikita A Mehta; E Jennifer Edelman; Trace Kershaw; Philip A Chan
Journal:  AIDS Behav       Date:  2022-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.